Steven Cohen's ABCL Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 976,507 shares of AbCellera Biologics Inc. (ABCL) worth $3.34 M, representing 0.00% of the portfolio. First purchased in 2020-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ABCL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 976,507 shares. Largest reduction occurred in Q4 2021, reducing 272,984 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AbCellera Biologics (ABCL) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbCellera Biologics (ABCL) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2020 | +55,000 | New Buy | 55,000 | $40.24 |
| Q1 2021 | -55,000 | Sold Out | 0 | $0.00 |
| Q3 2021 | +272,984 | New Buy | 272,984 | $20.04 |
| Q4 2021 | -272,984 | Sold Out | 0 | $0.00 |
| Q2 2023 | +3,959 | New Buy | 3,959 | $6.46 |
| Q3 2023 | -3,959 | Sold Out | 0 | $0.00 |
| Q4 2025 | +976,507 | New Buy | 976,507 | $3.42 |
Steven Cohen's AbCellera Biologics Investment FAQs
Steven Cohen first purchased AbCellera Biologics Inc. (ABCL) in Q4 2020, acquiring 55,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AbCellera Biologics Inc. (ABCL) for 7 quarters since Q4 2020.
Steven Cohen's largest addition to AbCellera Biologics Inc. (ABCL) was in Q4 2025, adding 976,507 shares worth $3.34 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 976,507 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $3.34 M.
As of the Q4 2025 filing, AbCellera Biologics Inc. (ABCL) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in AbCellera Biologics Inc. (ABCL) was 976,507 shares, as reported at the end of Q4 2025.